These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 18790633

  • 1. Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
    Huang CL, Liu D, Ishikawa S, Nakashima T, Nakashima N, Yokomise H, Kadota K, Ueno M.
    Eur J Cancer; 2008 Nov; 44(17):2680-8. PubMed ID: 18790633
    [Abstract] [Full Text] [Related]

  • 2. Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients.
    Nakashima T, Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M, Kadota K, Huang CL.
    Oncol Rep; 2008 Jan; 19(1):203-9. PubMed ID: 18097596
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis.
    Leinonen T, Pirinen R, Böhm J, Johansson R, Ropponen K, Kosma VM.
    Lung Cancer; 2006 Mar; 51(3):313-21. PubMed ID: 16423426
    [Abstract] [Full Text] [Related]

  • 8. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
    Dosaka-Akita H, Hommura F, Mishina T, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Cancer Res; 2001 Mar 15; 61(6):2500-4. PubMed ID: 11289121
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer.
    Nakashima T, Huang CL, Liu D, Kameyama K, Masuya D, Ueno M, Haba R, Yokomise H.
    Med Sci Monit; 2004 Jun 15; 10(6):BR157-65. PubMed ID: 15173661
    [Abstract] [Full Text] [Related]

  • 11. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer.
    Takenaka K, Ishikawa S, Kawano Y, Yanagihara K, Miyahara R, Otake Y, Morioka Y, Takahashi C, Noda M, Wada H, Tanaka F.
    Eur J Cancer; 2004 Jul 15; 40(10):1617-23. PubMed ID: 15196549
    [Abstract] [Full Text] [Related]

  • 12. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
    Dai WB, Ren ZP, Chen WL, DU J, Shi Z, Tang DY.
    Ai Zheng; 2007 Sep 15; 26(9):963-6. PubMed ID: 17927853
    [Abstract] [Full Text] [Related]

  • 13. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
    Bremnes RM, Camps C, Sirera R.
    Lung Cancer; 2006 Feb 15; 51(2):143-58. PubMed ID: 16360975
    [Abstract] [Full Text] [Related]

  • 14. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL, Liu D, Nakano J, Yokomise H, Ueno M, Kadota K, Wada H.
    Clin Cancer Res; 2007 Dec 01; 13(23):6938-46. PubMed ID: 18056168
    [Abstract] [Full Text] [Related]

  • 15. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer.
    Keum JS, Kong G, Yang SC, Shin DH, Park SS, Lee JH, Lee JD.
    Br J Cancer; 1999 Sep 01; 81(1):127-32. PubMed ID: 10487623
    [Abstract] [Full Text] [Related]

  • 16. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.
    Chen F, Takenaka K, Ogawa E, Yanagihara K, Otake Y, Wada H, Tanaka F.
    Clin Cancer Res; 2004 Dec 15; 10(24):8548-53. PubMed ID: 15623638
    [Abstract] [Full Text] [Related]

  • 17. Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.
    Giatromanolaki A, Koukourakis MI, O'Byrne K, Kaklamanis L, Dicoglou C, Trichia E, Whitehouse R, Harris AL, Gatter KC.
    Anticancer Res; 1996 Dec 15; 16(6B):3819-25. PubMed ID: 9042264
    [Abstract] [Full Text] [Related]

  • 18. Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer.
    Mino N, Takenaka K, Sonobe M, Miyahara R, Yanagihara K, Otake Y, Wada H, Tanaka F.
    J Surg Oncol; 2007 Mar 01; 95(3):250-7. PubMed ID: 17323339
    [Abstract] [Full Text] [Related]

  • 19. [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].
    Zhang HZ, Wei YP, Li HG, Wang M, Liu JG, Wu C.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep 01; 26(9):1307-10. PubMed ID: 16982442
    [Abstract] [Full Text] [Related]

  • 20. Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma.
    Boldrini L, Gisfredi S, Ursino S, Faviana P, Lucchi M, Melfi F, Mussi A, Basolo F, Fontanini G.
    Eur J Cancer; 2005 Dec 01; 41(18):2828-35. PubMed ID: 16298124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.